688319.SH
Chengdu Olymvax Biopharmaceuticals, Inc.
SSE · Healthcare · Biotechnology · CN
CNY 25.91
+2.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 114.26x
- P/E 2028E
- 82.13x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 471.88x
- PEG TTM
- —
- Price / book
- 12.08x
- Price / sales
- 13.76x
- Price / cash flow
- 102.87x
Enterprise value
- Enterprise value
- CNY 10.8B
- EV / sales
- 13.93x
- EV / EBITDA
- 154.90x
- EV / EBIT
- 153.53x
- Market cap
- CNY 10.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026